ILF2 anticorps (AA 1-390)
Aperçu rapide pour ILF2 anticorps (AA 1-390) (ABIN517145)
Antigène
Voir toutes ILF2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-390
-
Fonction
- Mouse polyclonal antibody raised against a full-length human ILF2 protein.
-
Séquence
- MRGDRGRGRG GRFGSRGGPG GGFRPFVPHI PFDFYLCEMA FPRVKPAPDE TSFSEALLKR NQDLAPNSAE QASILSLVTK INNVIDNLIV APGTFEVQIE EVRQVGSYKK GTMTTGHNVA DLVVILKILP TLEAVAALGN KVVESLRAQD PSEVLTMLTN ETGFEISSSD ATVKILITTV PPNLRKLDPE LHLDIKVLQS ALAAIRHARW FEENASQSTV KVLIRLLKDL RIRFPGFEPL TPWILDLLGH YAVMNNPTRQ PLALNVAYRR CLQILAAGLF LPGSVGITDP CESGNFRVHT VMTLEQQDMV CYTAQTLVRI LSHGGFRKIL GQEGDASYLA SEISTWDGVI VTPSEKAYEK PPEKKEGEEE EENTEEPPQG EEEESMETQE
-
Réactivité croisée
- Humain
-
Attributs du produit
- Antibody reactive against mammalian transfected lysate.
-
Immunogène
- ILF2 (NP_004506.2, 1 a.a. ~ 390 a.a) full-length human protein.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Inferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models." dans: Biotechnology and bioengineering, Vol. 111, Issue 9, pp. 1853-63, (2014) (PubMed).
-
: "Inferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models." dans: Biotechnology and bioengineering, Vol. 111, Issue 9, pp. 1853-63, (2014) (PubMed).
-
- ILF2 (Interleukin Enhancer Binding Factor 2, 45kDa (ILF2))
-
Autre désignation
- ILF2
-
Sujet
-
Full Gene Name: interleukin enhancer binding factor 2, 45 kDa
Synonyms: MGC8391,NF45,PRO3063 -
ID gène
- 3608
-
NCBI Accession
- NM_004515
Antigène
-